Posted on 05/22/2020 8:33:41 AM PDT by SeekAndFind
A COVID-19 vaccine trial at Oxford University in the U.K. is “progressing very well,” according to researchers involved in the project.
“The clinical studies are progressing very well and we are now initiating studies to evaluate how well the vaccine induces immune responses in older adults, and to test whether it can provide protection in the wider population,” said Professor Andrew Pollard, head of the Oxford Vaccine Group, in a statement released Friday. “We are very grateful to the huge support of the trial volunteers in helping test whether this new vaccine could protect humans against the pandemic coronavirus.”
The same investigational vaccine protected six monkeys from pneumonia caused by the virus. The ChAdOx1 nCoV-19 vaccine is made from the ChAdOx1 virus, a weakened version of the common cold that has been genetically changed so that it is impossible for it to replicate in humans, according to the Oxford researchers.
Researchers have started recruiting in the next phase of human trials for the COVID-19 vaccine. The Phase I trial in healthy adult volunteers began in April and more than 1,000 immunizations have been completed, the researchers said, noting that follow-up is currently ongoing.
Fox News has reached out to Oxford University and the Medicines and Healthcare products Regulatory Agency with a request for comment. The MHRA oversees drug trials in the U.K.
“The next study will enroll up to 10,260 adults and children and will involve a number of partner institutions across the country,” they explained in the statement. Phase II of the study will involve a small number of older adults aged 56 to 59 and over 70, as well as children aged 5 to 12.
“For these groups, researchers will be assessing the immune response to the vaccine in people of different ages,
(Excerpt) Read more at foxnews.com ...
Same place the Imperial Model came from, right?
RE: Same place the Imperial Model came from, right?
No, Oxford is Oxford, the London Imperial College is different. That’s like comparing Harvard with Yale.
Right, using common cold virus to make covid19 vaccine???? But not vaccine for the cold.. OK I got swamp land in Minnesota to sell
The vaccine is for the Karen’s. Not intelligent well
Informed people
Good. Competition with Moderna. I was a combat engineer—combat type. You wouldn’t believe some of the things we were vaccinated for. Get the vaccine ready by October, and I’ll take it.
RE: You wouldn’t believe some of the things we were vaccinated for
Were these vaccines already tested for some time, or were you in the military made the guinea pigs?
It’s likely that some of them weren’t tested as extensively as the civilian vaccines. Soldiers need to be prepared as well as possible for any missions that might be needed, wherever. The only very noticeable side effects for me were from one of them: fever and night sweats the following night or two. Not too bad. No serious side effects for the others in my units, either.
There was one in initial training who reacted to a smallpox vaccination—no joke. Instead of one little blister, he had a whole mess of them. He was rushed to the hospital but came right out okay.
Those of us who weren’t otherwise injured in training were very healthy for a few years in spite of fatigue and very unsanitary conditions at times for weeks.
"A recombinant trimeric Spike-protein (S-Trimer) subunit vaccine, using it's Trimer-Tag technology delivered through a vector, for prevention of COVID-19; in February 2020, preclinical studies using Glaxosmithkline (Gates company) plc's pandemic vaccine adjuvant technology with the vaccine were planned"
"Mene Pangalos, Executive Vice President, BioPharmaceuticals R&D, AstraZeneca, said: “The University of Oxford and AstraZeneca have a longstanding relationship to advance basic research"
Ah yes, Oxford is the one that made the other completely wrong model.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.